Use este identificador para citar ou linkar para este item: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1178994
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorNOBRE, M. R.eng
dc.contributor.authorPINTO, D. dos S. C.eng
dc.contributor.authorLOURES, M. D. de A.eng
dc.contributor.authorLÉPORI, C.eng
dc.contributor.authorFERRANTE, M.eng
dc.contributor.authorBRANDAO, H. de M.eng
dc.date.accessioned2025-09-22T16:48:49Z-
dc.date.available2025-09-22T16:48:49Z-
dc.date.created2025-09-22
dc.date.issued2025
dc.identifier.citationIn: CONFERENCE OF THE WORLD ASSOCIATION FOR THE ADVANCEMENTS OF VETERINARY PARASITOLOGY, 30., 2025, Curitiba. Abstract book. Curitiba: Universidade Federal do Paraná, 2025.
dc.identifier.urihttp://www.alice.cnptia.embrapa.br/alice/handle/doc/1178994-
dc.descriptionTrichomonosis is a venereal disease of cattle caused by the flagellated protozoan Tritrichomonas fetus. In males, the protozoan is found in the mucosa of the preputial cavity, and in older animals, the increase in the size of the preputial crypts creates a microenvironment conducive to the survival of the pathogen.
dc.language.isoeng
dc.rightsopenAccess
dc.titleDevelopment of a nanocarrier pharmaceutical formulation containing metronidazole for the topical treatment of bovine trichomoniasis.
dc.typeResumo em anais e proceedings
dc.subject.thesagroBovino
dc.subject.thesagroDoença Animal
dc.subject.thesagroTricomonose
dc.format.extent2p. 357.
riaa.ainfo.id1178994
riaa.ainfo.lastupdate2025-09-22
dc.contributor.institutionMATHEUS RESENDE NOBRE, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionDANIELLE DOS SANTOS CINELLI PINTO, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionMICHELLE DAIANE DE ALMEIDA LOURES, CNPGLeng
dc.contributor.institutionCRISTIAN LÉPORI, UNIVERSIDADE NACIONAL DE RIO CUARTOeng
dc.contributor.institutionMARCOS FERRANTE, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionHUMBERTO DE MELLO BRANDAO, CNPGL.eng
Aparece nas coleções:Resumo em anais de congresso (CNPGL)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Development-of-a-nanocarrier-pharmaceutical-formulation.pdf460.93 kBAdobe PDFThumbnail
Visualizar/Abrir

FacebookTwitterDeliciousLinkedInGoogle BookmarksMySpace